Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13598* | 2021 |
Mitochondrial complex I deficiency in Parkinson's disease AHV Schapira, JM Cooper, D Dexter, JB Clark, P Jenner, CD Marsden Journal of neurochemistry 54 (3), 823-827, 1990 | 2623 | 1990 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1958* | 2021 |
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans R Wilson, R Ainscough, K Anderson, C Baynes, M Berks, J Bonfield, ... Nature 368 (6466), 32-38, 1994 | 1847 | 1994 |
Mitochondrial complex I defi ciency in Parkinson’s disease AHV Schapira, JM Cooper, D Dexter, P Jenner, JB Clark, CD Marsden LANCET 1, 1269-1269, 1989 | 1794 | 1989 |
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases MWJ Cleeter, JM Cooper, VM Darley-Usmar, S Moncada, AHV Schapira FEBS letters 345 (1), 50-54, 1994 | 1594 | 1994 |
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy ME Gegg, JM Cooper, KY Chau, M Rojo, AHV Schapira, JW Taanman Human molecular genetics 19 (24), 4861-4870, 2010 | 1077 | 2010 |
Mitochondrial defect in Huntington's disease caudate nucleus M Gu, MT Gash, VM Mann, F Javoy‐Agid, JM Cooper, AHV Schapira Annals of Neurology: Official Journal of the American Neurological …, 1996 | 918 | 1996 |
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease AHV Schapira, VM Mann, JM Cooper, D Dexter, SE Daniel, P Jenner, ... Journal of neurochemistry 55 (6), 2142-2145, 1990 | 850 | 1990 |
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission L Alvarez-Erviti, Y Seow, AH Schapira, C Gardiner, IL Sargent, MJA Wood, ... Neurobiology of disease 42 (3), 360-367, 2011 | 849 | 2011 |
Chaperone-mediated autophagy markers in Parkinson disease brains L Alvarez-Erviti, MC Rodriguez-Oroz, JM Cooper, C Caballero, I Ferrer, ... Archives of neurology 67 (12), 1464-1472, 2010 | 674 | 2010 |
A review of the immobilization of enzymes in electropolymerized films PN Bartlett, JM Cooper Journal of Electroanalytical Chemistry 362 (1-2), 1-12, 1993 | 664 | 1993 |
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains ME Gegg, D Burke, SJR Heales, JM Cooper, J Hardy, NW Wood, ... Annals of neurology 72 (3), 455-463, 2012 | 613 | 2012 |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body P Ashton, RA Patchell, J Cooper, BA Young US Patent 5,836,935, 1998 | 613 | 1998 |
A novel α-synuclein missense mutation in Parkinson disease C Proukakis, CG Dudzik, T Brier, DS MacKay, JM Cooper, GL Millhauser, ... Neurology 80 (11), 1062-1064, 2013 | 591 | 2013 |
Biochemical abnormalities and excitotoxicity in Huntington's disease brain SJ Tabrizi, MWJ Cleeter, J Xuereb, JW Taanman, JM Cooper, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 563 | 1999 |
Chaste: an open source C++ library for computational physiology and biology GR Mirams, CJ Arthurs, MO Bernabeu, R Bordas, J Cooper, A Corrias, ... PLoS computational biology 9 (3), e1002970, 2013 | 519 | 2013 |
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice JM Cooper, PBO Wiklander, JZ Nordin, R Al‐Shawi, MJ Wood, M Vithlani, ... Movement Disorders 29 (12), 1476-1485, 2014 | 518 | 2014 |
Irreversible inhibition of mitochondrial complex I by 1‐methyl‐4‐phenylpyridinium: evidence for free radical involvement MWJ Cleeter, JM Cooper, AHV Schapira Journal of neurochemistry 58 (2), 786-789, 1992 | 495 | 1992 |
Biosensors: a practical approach AEG Cass (No Title), 1990 | 485* | 1990 |